Sanofi has instituted a copay program for the purchase of Auvi-Q epinephrine auto-injectors. After the first $25, the firm will reimburse up to $100 each for up to two auto-injectors.
Readers can learn more and sign up for the “Let’s Talk Auvi-Q Support Program” by clicking here.
The Auvi-Q is the world’s first “talking” auto-injector, guiding the administrator through each step of the injection process with voice prompts. You can see a video demonstration of the Auvi-Q here.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
I saw this as news on your site and was wondering if this is this a new program from Sanofi, or this the same one they have had all along? I couldn’t tell from following the link. Thanks for pointing it out in any case!
The copay savings increased from $60 off to now $100 off.